Impact of past use of disease-modifying anti-rheumatic drugs on Rheumatoid Arthritis treatment using JAKis - Data from the Fukui Ishikawa Toyama Database of Rheumatoid Arthritis
Latest Information Update: 29 Jun 2022
At a glance
- Drugs Baricitinib (Primary) ; Peficitinib (Primary) ; Tofacitinib (Primary) ; Upadacitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 29 Jun 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism